These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

486 related items for PubMed ID: 13129873

  • 21. Scleritis and systemic disease association in a community-based referral practice.
    Raiji VR, Palestine AG, Parver DL.
    Am J Ophthalmol; 2009 Dec; 148(6):946-50. PubMed ID: 19837380
    [Abstract] [Full Text] [Related]

  • 22. Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders.
    Baltatzis S, Tufail F, Yu EN, Vredeveld CM, Foster CS.
    Ophthalmology; 2003 May; 110(5):1061-5. PubMed ID: 12750115
    [Abstract] [Full Text] [Related]

  • 23. [Mycophenolate mofetil in the treatment of primary nephrotic syndrome].
    Zhao M, Chen X, Chen Y, Liu Z, Liu Y, Lu F, Zhang Y, Wang H.
    Zhonghua Yi Xue Za Zhi; 2001 May 10; 81(9):528-31. PubMed ID: 11809115
    [Abstract] [Full Text] [Related]

  • 24. Long-term efficacy of mycophenolate mofetil in the control of severe intraocular inflammation.
    Lau CH, Comer M, Lightman S.
    Clin Exp Ophthalmol; 2003 Dec 10; 31(6):487-91. PubMed ID: 14641155
    [Abstract] [Full Text] [Related]

  • 25. [Indication and effect of immunosuppression in patients with scleritis].
    Heiligenhaus A, Dück N, Michel D, Hudde T, Koch J, Steuhl KP.
    Klin Monbl Augenheilkd; 2003 Jul 10; 220(7):471-80. PubMed ID: 12886507
    [Abstract] [Full Text] [Related]

  • 26. Mycophenolate mofetil as a first-line steroid-sparing agent in the treatment of pemphigus vulgaris.
    Vyas N, Patel NS, Cohen GF.
    J Drugs Dermatol; 2013 Feb 10; 12(2):210-6. PubMed ID: 23377396
    [Abstract] [Full Text] [Related]

  • 27. Mycophenolate mofetil (CellCept): an alternative therapy for autoimmune inflammatory myopathy.
    Majithia V, Harisdangkul V.
    Rheumatology (Oxford); 2005 Mar 10; 44(3):386-9. PubMed ID: 15572389
    [Abstract] [Full Text] [Related]

  • 28. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 1998 Jan 27; 65(2):235-41. PubMed ID: 9458021
    [Abstract] [Full Text] [Related]

  • 29. Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease?
    Miehsler W, Reinisch W, Moser G, Gangl A, Vogelsang H.
    Am J Gastroenterol; 2001 Mar 27; 96(3):782-7. PubMed ID: 11280551
    [Abstract] [Full Text] [Related]

  • 30. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Transplantation; 1996 Apr 15; 61(7):1029-37. PubMed ID: 8623181
    [Abstract] [Full Text] [Related]

  • 31. Long-term results of therapy with mycophenolate mofetil in chronic non-infectious uveitis.
    Doycheva D, Zierhut M, Blumenstock G, Stuebiger N, Deuter C.
    Graefes Arch Clin Exp Ophthalmol; 2011 Aug 15; 249(8):1235-43. PubMed ID: 21720813
    [Abstract] [Full Text] [Related]

  • 32. Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study.
    Orth T, Peters M, Schlaak JF, Krummenauer F, Wanitschke R, Mayet WJ, Galle PR, Neurath MF.
    Am J Gastroenterol; 2000 May 15; 95(5):1201-7. PubMed ID: 10811328
    [Abstract] [Full Text] [Related]

  • 33. Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center.
    Lourdudoss C, Vollenhoven Rv.
    Lupus; 2014 Mar 15; 23(3):299-304. PubMed ID: 24399811
    [Abstract] [Full Text] [Related]

  • 34. Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial.
    Rathinam SR, Gonzales JA, Thundikandy R, Kanakath A, Murugan SB, Vedhanayaki R, Lim LL, Suhler EB, Al-Dhibi HA, Doan T, Keenan JD, Rao MM, Ebert CD, Nguyen HH, Kim E, Porco TC, Acharya NR, FAST Research Group.
    JAMA; 2019 Sep 10; 322(10):936-945. PubMed ID: 31503307
    [Abstract] [Full Text] [Related]

  • 35. Delayed severe pneumonia in mycophenolate mofetil-treated patients with IgA nephropathy.
    Lv J, Zhang H, Cui Z, Su T, Zhang Y, Wang H.
    Nephrol Dial Transplant; 2008 Sep 10; 23(9):2868-72. PubMed ID: 18463325
    [Abstract] [Full Text] [Related]

  • 36. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
    Transplantation; 1996 Mar 15; 61(5):722-9. PubMed ID: 8607174
    [Abstract] [Full Text] [Related]

  • 37. Treatment of mucous membrane pemphigoid with mycophenolate mofetil.
    Nottage JM, Hammersmith KM, Murchison AP, Felipe AF, Penne R, Raber I.
    Cornea; 2013 Jun 15; 32(6):810-5. PubMed ID: 23132447
    [Abstract] [Full Text] [Related]

  • 38. Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis.
    Shinjo SK, Pereira RM, Tizziani VA, Radu AS, Levy-Neto M.
    Clin Rheumatol; 2007 Nov 15; 26(11):1871-5. PubMed ID: 17332971
    [Abstract] [Full Text] [Related]

  • 39. Incidence of leukopenia and cytomegalovirus disease in kidney transplants treated with mycophenolate mofetil combined with low cyclosporine and steroid doses.
    Moreso F, Serón D, Morales JM, Cruzado JM, Gil-Vernet S, Pérez JL, Fulladosa X, Andrés A, Grinyó JM.
    Clin Transplant; 1998 Jun 15; 12(3):198-205. PubMed ID: 9642510
    [Abstract] [Full Text] [Related]

  • 40. A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis.
    Rathinam SR, Babu M, Thundikandy R, Kanakath A, Nardone N, Esterberg E, Lee SM, Enanoria WT, Porco TC, Browne EN, Weinrib R, Acharya NR.
    Ophthalmology; 2014 Oct 15; 121(10):1863-70. PubMed ID: 24917273
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.